Search

Your search keyword '"Parihar, Mayur"' showing total 235 results
Start Over Author "Parihar, Mayur"
235 results on '"Parihar, Mayur"'

4. HLA in Hematopoietic Stem Cell Transplantation

Author

Mishra, Deepak Kumar, Banerjee, Saheli, Arora, Neeraj, Parihar, Mayur, Radhakrishnan, Vivek, Section editor, Doria, Cataldo, Series Editor, Chandy, Mammen, editor, Radhakrishnan, Vivek S., editor, and Sukumaran, Reghu K., editor

Published
2021
Full Text
View/download PDF

6. Two novel cell culture models of buccal mucosal oral cancer from patients with no risk-habits of tobacco smoking or chewing

Author

Vipparthi, Kavya, Patel, Ankit Kumar, Ghosh, Subhashis, Das, Subrata, Das, Chitrarpita, Das, Koyeli, Sarkar, Anwesha, Thatikonda, Venu, Pal, Biswajoy, Remani, Arun Sasi kumaran Nair, Arora, Neeraj, Parihar, Mayur, Vijayakumar, Maleppillil Vavachan, Bhat, Manoj Kumar, Boppana, Ramanamurthy, Bhattacharjee, Samsiddhi, Biswas, Nidhan Kumar, Arun, Pattatheyil, Sharan, Rajeev, and Singh, Sandeep

Published
2021
Full Text
View/download PDF

7. Safety and Efficacy of Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Updated Data from an Ongoing Single Arm Phase-II Investigator- Initiated Clinical Trial (PRIME Study)

Author

Kumar, Jeevan, primary, Pincha, Rajat, additional, Radhakrishnan, Vivek S, additional, Tamboli, Naveed, additional, Nag, Arijit, additional, Podder, Dibakar, additional, Chattopadhyay, Debranjani, additional, Bhave, Saurabh Jayant, additional, Das, Sreya, additional, Parihar, Mayur, additional, Rath, Asish, additional, Vinarkar, Sushant, additional, Mukhopadhyay, Sumit, additional, Chakraborty, Subhosmito, additional, Mishra, Deepak Kumar, additional, Chandy, Mammen, additional, and Nair, Reena, additional

Published
2023
Full Text
View/download PDF

17. Signet ring cell lymphoma of follicular type with BCL2 gene rearrangement: A rare case with a short review of literature

Author

Mishra, Pritinanda, Adhya, Amit, Kar, Madhabananda, Parihar, Mayur, Samal, Swagatika, and Sable, Mukund

Subjects
Adenocarcinoma -- Case studies -- Diagnosis -- Drug therapy, Lymphatic diseases -- Case studies -- Diagnosis -- Drug therapy, Health
Abstract

Byline: Pritinanda. Mishra, Amit. Adhya, Madhabananda. Kar, Mayur. Parihar, Swagatika. Samal, Mukund. Sable A case of signet ring cell lymphoma of presacral lymph node is reported. The patient was diagnosed [...]

Published
2022

18. Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group

Author

Nair, Reena, Kakroo, Abhishek, Bapna, Ajay, Gogia, Ajay, Vora, Amish, Pathak, Anand, Korula, Anu, Chakrapani, Anupam, Doval, Dinesh, Prakash, Gaurav, Biswas, Ghanashyam, Menon, Hari, Bhattacharya, Maitreyee, Chandy, Mammen, Parihar, Mayur, Vamshi Krishna, M., Arora, Neeraj, Gadhyalpatil, Nikhil, Malhotra, Pankaj, Narayanan, Prasad, Nair, Rekha, Basu, Rimpa, Shah, Sandip, Bhave, Saurabh, Bondarde, Shailesh, Bhartiya, Shilpa, Nityanand, Soniya, Gujral, Sumeet, Tilak, T. V. S., and Radhakrishnan, Vivek

Published
2018
Full Text
View/download PDF

21. Data from The Genetic Basis of Hepatosplenic T-cell Lymphoma

Author

McKinney, Matthew, primary, Moffitt, Andrea B., primary, Gaulard, Philippe, primary, Travert, Marion, primary, De Leval, Laurence, primary, Nicolae, Alina, primary, Raffeld, Mark, primary, Jaffe, Elaine S., primary, Pittaluga, Stefania, primary, Xi, Liqiang, primary, Heavican, Tayla, primary, Iqbal, Javeed, primary, Belhadj, Karim, primary, Delfau-Larue, Marie Helene, primary, Fataccioli, Virginie, primary, Czader, Magdalena B., primary, Lossos, Izidore S., primary, Chapman-Fredricks, Jennifer R., primary, Richards, Kristy L., primary, Fedoriw, Yuri, primary, Ondrejka, Sarah L., primary, Hsi, Eric D., primary, Low, Lawrence, primary, Weisenburger, Dennis, primary, Chan, Wing C., primary, Mehta-Shah, Neha, primary, Horwitz, Steven, primary, Bernal-Mizrachi, Leon, primary, Flowers, Christopher R., primary, Beaven, Anne W., primary, Parihar, Mayur, primary, Baseggio, Lucile, primary, Parrens, Marie, primary, Moreau, Anne, primary, Sujobert, Pierre, primary, Pilichowska, Monika, primary, Evens, Andrew M., primary, Chadburn, Amy, primary, Au-Yeung, Rex K.H., primary, Srivastava, Gopesh, primary, Choi, William W. L., primary, Goodlad, John R., primary, Aurer, Igor, primary, Basic-Kinda, Sandra, primary, Gascoyne, Randy D., primary, Davis, Nicholas S., primary, Li, Guojie, primary, Zhang, Jenny, primary, Rajagopalan, Deepthi, primary, Reddy, Anupama, primary, Love, Cassandra, primary, Levy, Shawn, primary, Zhuang, Yuan, primary, Datta, Jyotishka, primary, Dunson, David B., primary, and Davé, Sandeep S., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Tables S1 - S10 from The Genetic Basis of Hepatosplenic T-cell Lymphoma

Author

McKinney, Matthew, primary, Moffitt, Andrea B., primary, Gaulard, Philippe, primary, Travert, Marion, primary, De Leval, Laurence, primary, Nicolae, Alina, primary, Raffeld, Mark, primary, Jaffe, Elaine S., primary, Pittaluga, Stefania, primary, Xi, Liqiang, primary, Heavican, Tayla, primary, Iqbal, Javeed, primary, Belhadj, Karim, primary, Delfau-Larue, Marie Helene, primary, Fataccioli, Virginie, primary, Czader, Magdalena B., primary, Lossos, Izidore S., primary, Chapman-Fredricks, Jennifer R., primary, Richards, Kristy L., primary, Fedoriw, Yuri, primary, Ondrejka, Sarah L., primary, Hsi, Eric D., primary, Low, Lawrence, primary, Weisenburger, Dennis, primary, Chan, Wing C., primary, Mehta-Shah, Neha, primary, Horwitz, Steven, primary, Bernal-Mizrachi, Leon, primary, Flowers, Christopher R., primary, Beaven, Anne W., primary, Parihar, Mayur, primary, Baseggio, Lucile, primary, Parrens, Marie, primary, Moreau, Anne, primary, Sujobert, Pierre, primary, Pilichowska, Monika, primary, Evens, Andrew M., primary, Chadburn, Amy, primary, Au-Yeung, Rex K.H., primary, Srivastava, Gopesh, primary, Choi, William W. L., primary, Goodlad, John R., primary, Aurer, Igor, primary, Basic-Kinda, Sandra, primary, Gascoyne, Randy D., primary, Davis, Nicholas S., primary, Li, Guojie, primary, Zhang, Jenny, primary, Rajagopalan, Deepthi, primary, Reddy, Anupama, primary, Love, Cassandra, primary, Levy, Shawn, primary, Zhuang, Yuan, primary, Datta, Jyotishka, primary, Dunson, David B., primary, and Davé, Sandeep S., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Methods, Figures S1 - S9 from The Genetic Basis of Hepatosplenic T-cell Lymphoma

Author

McKinney, Matthew, primary, Moffitt, Andrea B., primary, Gaulard, Philippe, primary, Travert, Marion, primary, De Leval, Laurence, primary, Nicolae, Alina, primary, Raffeld, Mark, primary, Jaffe, Elaine S., primary, Pittaluga, Stefania, primary, Xi, Liqiang, primary, Heavican, Tayla, primary, Iqbal, Javeed, primary, Belhadj, Karim, primary, Delfau-Larue, Marie Helene, primary, Fataccioli, Virginie, primary, Czader, Magdalena B., primary, Lossos, Izidore S., primary, Chapman-Fredricks, Jennifer R., primary, Richards, Kristy L., primary, Fedoriw, Yuri, primary, Ondrejka, Sarah L., primary, Hsi, Eric D., primary, Low, Lawrence, primary, Weisenburger, Dennis, primary, Chan, Wing C., primary, Mehta-Shah, Neha, primary, Horwitz, Steven, primary, Bernal-Mizrachi, Leon, primary, Flowers, Christopher R., primary, Beaven, Anne W., primary, Parihar, Mayur, primary, Baseggio, Lucile, primary, Parrens, Marie, primary, Moreau, Anne, primary, Sujobert, Pierre, primary, Pilichowska, Monika, primary, Evens, Andrew M., primary, Chadburn, Amy, primary, Au-Yeung, Rex K.H., primary, Srivastava, Gopesh, primary, Choi, William W. L., primary, Goodlad, John R., primary, Aurer, Igor, primary, Basic-Kinda, Sandra, primary, Gascoyne, Randy D., primary, Davis, Nicholas S., primary, Li, Guojie, primary, Zhang, Jenny, primary, Rajagopalan, Deepthi, primary, Reddy, Anupama, primary, Love, Cassandra, primary, Levy, Shawn, primary, Zhuang, Yuan, primary, Datta, Jyotishka, primary, Dunson, David B., primary, and Davé, Sandeep S., primary

Published
2023
Full Text
View/download PDF

24. Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement

Author

Bomken, S, Enshaei, A, Schwalbe, E, Mikulasova, A, Dai, Y, Zaka, M, Fung, K, Bashton, M, Lim, H, Jones, L, Karataraki, N, Winterman, E, Ashby, C, Attarbaschi, A, Bertrand, Y, Bradtke, J, Buldini, B, Burke, G, Cazzaniga, G, Gohring, G, De Groot-Kruseman, H, Haferlach, C, Nigro, L, Parihar, M, Plesa, A, Seaford, E, Sonneveld, E, Strehl, S, Van der Velden, V, Rand, V, Hunger, S, Harrison, C, Bacon, C, Van Delft, F, Loh, M, Moppett, J, Vormoor, J, Walker, B, Moorman, A, Russell, L, Bomken, Simon, Enshaei, Amir, Schwalbe, Edward C, Mikulasova, Aneta, Dai, Yunfeng, Zaka, Masood, Fung, Kent Tm, Bashton, Matthew, Lim, Huezin, Jones, Lisa, Karataraki, Nefeli, Winterman, Emily, Ashby, Cody, Attarbaschi, Andishe, Bertrand, Yves, Bradtke, Jutta, Buldini, Barbara, Burke, G. A. Amos, Cazzaniga, Giovanni, Gohring, Gudrun, De Groot-Kruseman, Hesta A, Haferlach, Claudia, Nigro, Luca Lo, Parihar, Mayur, Plesa, Adriana, Seaford, Emma, Sonneveld, Edwin, Strehl, Sabine, Van der Velden, Vincent Hj, Rand, Vikki, Hunger, Stephen P, Harrison, Christine J, Bacon, Chris M, Van Delft, Frederik W, Loh, Mignon L, Moppett, John, Vormoor, Josef, Walker, Brian A, Moorman, Anthony V, Russell, Lisa J, Bomken, S, Enshaei, A, Schwalbe, E, Mikulasova, A, Dai, Y, Zaka, M, Fung, K, Bashton, M, Lim, H, Jones, L, Karataraki, N, Winterman, E, Ashby, C, Attarbaschi, A, Bertrand, Y, Bradtke, J, Buldini, B, Burke, G, Cazzaniga, G, Gohring, G, De Groot-Kruseman, H, Haferlach, C, Nigro, L, Parihar, M, Plesa, A, Seaford, E, Sonneveld, E, Strehl, S, Van der Velden, V, Rand, V, Hunger, S, Harrison, C, Bacon, C, Van Delft, F, Loh, M, Moppett, J, Vormoor, J, Walker, B, Moorman, A, Russell, L, Bomken, Simon, Enshaei, Amir, Schwalbe, Edward C, Mikulasova, Aneta, Dai, Yunfeng, Zaka, Masood, Fung, Kent Tm, Bashton, Matthew, Lim, Huezin, Jones, Lisa, Karataraki, Nefeli, Winterman, Emily, Ashby, Cody, Attarbaschi, Andishe, Bertrand, Yves, Bradtke, Jutta, Buldini, Barbara, Burke, G. A. Amos, Cazzaniga, Giovanni, Gohring, Gudrun, De Groot-Kruseman, Hesta A, Haferlach, Claudia, Nigro, Luca Lo, Parihar, Mayur, Plesa, Adriana, Seaford, Emma, Sonneveld, Edwin, Strehl, Sabine, Van der Velden, Vincent Hj, Rand, Vikki, Hunger, Stephen P, Harrison, Christine J, Bacon, Chris M, Van Delft, Frederik W, Loh, Mignon L, Moppett, John, Vormoor, Josef, Walker, Brian A, Moorman, Anthony V, and Russell, Lisa J

Abstract

Rarely, immunophenotypically immature B-cell precursor acute lymphoblastic leukemia (BCP-ALL) carries an immunoglobulin-MYC rearrangement (IG-MYC-r). This can result in diagnostic confusion with Burkitt lymphoma/leukemia and use of individualized treatment schedules of unproven efficacy. Here we compare the molecular characteristics of these conditions and investigate historic clinical outcome data. We identified 90 cases registered in a national BCP-ALL clinical trial/registry. When present, diagnostic material underwent cytogenetic, exome, methylome and transcriptome analyses. The outcomes analyzed were 3-year event-free survival and overall survival. IG-MYC-r was identified in diverse cytogenetic backgrounds, co-existing with either established BCP-ALL-specific abnormalities (high hyperdiploidy, n=3; KMT2A-rearrangement, n=6; iAMP21, n=1; BCR-ABL1, n=1); BCL2/BCL6-rearrangements (n=15); or, most commonly, as the only defining feature (n=64). Within this final group, precursor-like V(D)J breakpoints predominated (8/9) and KRAS mutations were common (5/11). DNA methylation identified a cluster of V(D)J-rearranged cases, clearly distinct from Burkitt leukemia/lymphoma. Children with IG-MYC-r within that subgroup had a 3-year event-free survival of 47% and overall survival of 60%, representing a high-risk BCP-ALL. To develop effective management strategies this group of patients must be allowed access to contemporary, minimal residual disease-adapted, prospective clinical trial protocols.

Published
2023

25. Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature.

Author

Kathrotiya, Manthan, Radhakrishnan, Vivek, Bhave, Saurabh J., Nag, Arijit, Arora, Neeraj, Roychoudhry, Mita, Parihar, Mayur, Mishra, Deepak, Nair, Reena, Chandy, Mammen, and Kumar, Jeevan

Subjects
HEMATOPOIETIC stem cell transplantation, PATIENT experience, MULTIPLE myeloma, PATIENTS' attitudes, ELECTRONIC health records, MONOCLONAL gammopathies
Abstract

Introduction: High-dose chemotherapy with melphalan, followed by autologous hematopoietic stem cell transplantation (AHCT) remains the standard of care for consolidation therapy of fit patients with newly diagnosed multiple myeloma (NDMM), for more than 20 years now. Material and Methods: This is a retrospective study of NDMM patients who underwent AHCT at our center from 2011 to 2018. Data was undertaken using the hospital electronic medical records (EMR). Results: Among transplant eligible patients (which were 764), 78 patients (10.2%) underwent AHCT. The predominant stage in the study cohort was International Scoring System (ISS)-III (55%), and IgG-kappa (44%) was the commonest subtype of multiple myeloma (MM). Light chain myeloma was found in 23.5% of patients. Pretransplant, 42%, 48%, and 10% patients were in more than very good partial response (>VGPR), very good partial response (VGPR), and partial response (PR), respectively. The median duration of follow-up was 57.2 months (range: 12.1-120.2 months). The entire cohort's 5-year overall survival (OS) and progression-free survival (PFS) were 89.1% and 41.8%, respectively. Conclusion: Bortezomib based triplet induction regimens were effective and well tolerated in this retrospective analysis of Indian patients. We observed that AHCT effectively achieves deep and durable remission in MM. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

27. MM-466 Early Impressions With Use of BCMA-Directed Therapy: Elranatamab in Multiply Relapsed/Refractory Multiple Myeloma: A Safety and Efficacy Analysis in a Tertiary Cancer Center in India

Author

Podder, Dibakar, Patil, Noopur, Brahma, Anupam, Shewale, Sundar, Javed, Rizwan, Chattopadhyay, Debranjani, Ghosh, Shouriyo, Nag, Arijit, Kumar, Jeevan, Rath, Ashish, Vinarkar, Sushant, Parihar, Mayur, Mishra, Deepak, Chakraborty, Subhosmito, and Nair, Reena

Published
2024
Full Text
View/download PDF

32. Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement

Author

Bomken, S, Enshaei, A, Schwalbe, E, Mikulasova, A, Dai, Y, Zaka, M, Fung, K, Bashton, M, Lim, H, Jones, L, Karataraki, N, Winterman, E, Ashby, C, Attarbaschi, A, Bertrand, Y, Bradtke, J, Buldini, B, Burke, G, Cazzaniga, G, Gohring, G, De Groot-Kruseman, H, Haferlach, C, Nigro, L, Parihar, M, Plesa, A, Seaford, E, Sonneveld, E, Strehl, S, Van der Velden, V, Rand, V, Hunger, S, Harrison, C, Bacon, C, Van Delft, F, Loh, M, Moppett, J, Vormoor, J, Walker, B, Moorman, A, Russell, L, Bomken, Simon, Enshaei, Amir, Schwalbe, Edward C, Mikulasova, Aneta, Dai, Yunfeng, Zaka, Masood, Fung, Kent Tm, Bashton, Matthew, Lim, Huezin, Jones, Lisa, Karataraki, Nefeli, Winterman, Emily, Ashby, Cody, Attarbaschi, Andishe, Bertrand, Yves, Bradtke, Jutta, Buldini, Barbara, Burke, G. A. Amos, Cazzaniga, Giovanni, Gohring, Gudrun, De Groot-Kruseman, Hesta A, Haferlach, Claudia, Nigro, Luca Lo, Parihar, Mayur, Plesa, Adriana, Seaford, Emma, Sonneveld, Edwin, Strehl, Sabine, Van der Velden, Vincent Hj, Rand, Vikki, Hunger, Stephen P, Harrison, Christine J, Bacon, Chris M, Van Delft, Frederik W, Loh, Mignon L, Moppett, John, Vormoor, Josef, Walker, Brian A, Moorman, Anthony V, Russell, Lisa J, Bomken, S, Enshaei, A, Schwalbe, E, Mikulasova, A, Dai, Y, Zaka, M, Fung, K, Bashton, M, Lim, H, Jones, L, Karataraki, N, Winterman, E, Ashby, C, Attarbaschi, A, Bertrand, Y, Bradtke, J, Buldini, B, Burke, G, Cazzaniga, G, Gohring, G, De Groot-Kruseman, H, Haferlach, C, Nigro, L, Parihar, M, Plesa, A, Seaford, E, Sonneveld, E, Strehl, S, Van der Velden, V, Rand, V, Hunger, S, Harrison, C, Bacon, C, Van Delft, F, Loh, M, Moppett, J, Vormoor, J, Walker, B, Moorman, A, Russell, L, Bomken, Simon, Enshaei, Amir, Schwalbe, Edward C, Mikulasova, Aneta, Dai, Yunfeng, Zaka, Masood, Fung, Kent Tm, Bashton, Matthew, Lim, Huezin, Jones, Lisa, Karataraki, Nefeli, Winterman, Emily, Ashby, Cody, Attarbaschi, Andishe, Bertrand, Yves, Bradtke, Jutta, Buldini, Barbara, Burke, G. A. Amos, Cazzaniga, Giovanni, Gohring, Gudrun, De Groot-Kruseman, Hesta A, Haferlach, Claudia, Nigro, Luca Lo, Parihar, Mayur, Plesa, Adriana, Seaford, Emma, Sonneveld, Edwin, Strehl, Sabine, Van der Velden, Vincent Hj, Rand, Vikki, Hunger, Stephen P, Harrison, Christine J, Bacon, Chris M, Van Delft, Frederik W, Loh, Mignon L, Moppett, John, Vormoor, Josef, Walker, Brian A, Moorman, Anthony V, and Russell, Lisa J

Abstract

Rarely, immunophenotypically immature B-cell precursor acute lymphoblastic leukaemia (BCP-ALL) carries an immunoglobulin-MYC rearrangement (IG-MYC-r). This can result in diagnostic confusion with Burkitt lymphoma/leukaemia and use of unproven individualised treatment schedules. Here we contrast the molecular characteristics of these conditions and investigate historic clinical outcome data. We identified 90 cases registered on a national BCP-ALL clinical trial/registry. Where present, diagnostic material underwent cytogenetic, exome, methylome and transcriptome analysis. Outcome was analysed to define 3-year event free survival (EFS) and overall survival (OS). IG-MYC-r was identified in diverse cytogenetic backgrounds, co-existing with either: established BCP-ALL specific abnormalities (high hyperdiploidy n=3, KMT2A-rearrangement n=6, iAMP21 n=1, BCR-ABL n=1); BCL2/BCL6-rearrangements (n=15); or, most commonly, as the only defining feature (n=64). Within this final group, precursor-like V(D)J breakpoints predominated (8/9) and KRAS mutations were common (5/11). DNA methylation identified a cluster of V(D)J rearranged cases, clearly distinct from Burkitt leukaemia/lymphoma. Children with IG-MYC-r within that subgroup had 3-year EFS of 47% and OS of 60%, representing a high-risk BCP-ALL. To develop effective management strategies this patient group must be allowed access to contemporary, minimal residual disease adapted, prospective clinical trial protocols.

Published
2022

33. Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement

Author

Bomken, Simon, primary, Enshaei, Amir, additional, Schwalbe, Edward C, additional, Mikulasova, Aneta, additional, Dai, Yunfeng, additional, Zaka, Masood, additional, Fung, Kent TM, additional, Bashton, Matthew, additional, Lim, Huezin, additional, Jones, Lisa, additional, Karataraki, Nefeli, additional, Winterman, Emily, additional, Ashby, Cody, additional, Attarbaschi, Andishe, additional, Bertrand, Yves, additional, Bradtke, Jutte, additional, Buldini, Barbara, additional, Burke, GA Amos, additional, Cazzaniga, Giovanni, additional, Gohring, Gudrun, additional, De Groot-Kruseman, Hesta A, additional, Haferlach, Claudia, additional, Nigro, Luca Lo, additional, Parihar, Mayur, additional, Plesa, Adriana, additional, Seaford, Emma, additional, Sonneveld, Edwin, additional, Strehl, Sabine, additional, Van der Velden, Vincent HJ, additional, Rand, Vikki, additional, Hunger, Stephen P, additional, Harrison, Christine J, additional, Bacon, Chris M, additional, Van Delft, Frederik W, additional, Loh, Mignon L, additional, Moppett, John, additional, Vormoor, Josef, additional, Walker, Brian A, additional, Moorman, Anthony V, additional, and Russell, Lisa J, additional

Published
2022
Full Text
View/download PDF

34. Unique mutation and gene expression in High Hyperdiploid Acute Lymphoblastic Leukaemia with whole chromosome uniparental isodisomy

Author

Parihar, Mayur, primary, Ganguli, Debdutta, additional, Banerjee, Anindyajit, additional, Islam, Rubina, additional, Basu, Sangramjit, additional, Bhattacharya, Chumki, additional, Sarkar, Piyali, additional, Bhagwat, Shivani, additional, Ghose, Subhoshree, additional, Saha, Debparna, additional, Zaheer, Uzma, additional, Siddhanta, Ritam, additional, Paul, Pritha, additional, Sidhu, Jasmeet, additional, Das, Nandana, additional, Gogoi, Manash, additional, Chakraborty, Abhijit, additional, Varma, Binuja, additional, Sunderam, Uma, additional, Ramasubramaniam, Abhirami, additional, Biswas, Nidhan, additional, Das, Chitrarpita, additional, Singh, Manish, additional, Chakraborty, Barun, additional, Gorantla, Ashish, additional, Ghara, Niharendu, additional, Mishra, Deepak, additional, Krishnan, Shekhar, additional, Sriniva, Rajgopal, additional, and Saha, Vaskar, additional

Published
2022
Full Text
View/download PDF

36. Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: Real-World Evidence From a Middle-Income Setting and Literature Review

Author

Radhakrishnan, Vivek S., primary, Bajaj, Rajat, additional, Raina, Vasundhara, additional, Kumar, Jeevan, additional, Bhave, Saurabh J., additional, Sukumaran Nair, Reghu K., additional, Nag, Arijit, additional, Arun, Indu, additional, Zameer, Lateef, additional, Dey, Debdeep, additional, Arora, Neeraj, additional, Parihar, Mayur, additional, Das, Jayanta, additional, Achari, Rimpa B., additional, Mishra, Deepak K., additional, Chandy, Mammen, additional, and Nair, Reena, additional

Published
2022
Full Text
View/download PDF

38. Phenotypic similarities within the morphologic spectrum of DICER1‐associated sarcomas and pleuropulmonary blastoma: Histopathologic features guide diagnosis in the LMIC setting

Author

Roy, Paromita, primary, Das, Anirban, additional, Singh, Angad, additional, Panda, Joyshree, additional, Bhattacharya, Arpita, additional, Gehani, Anisha, additional, Parihar, Mayur, additional, K. S., Reghu, additional, Achari, Rimpa, additional, Alaggio, Rita, additional, Field, Amanda, additional, Hill, D. Ashley, additional, Dehner, Louis P., additional, and Schultz, Kris Ann P., additional

Published
2021
Full Text
View/download PDF

40. Induction Mortality in Acute Myeloid Leukemia: A 9 Year Retrospective Study from a Tertiary Care Centre in a Low-Middle Income Country Setting

Author

Radhakrishnan, Vivek S, primary, Pattnaik, Sandeep A, additional, Bhadhuri, Arunima, additional, Raina, Vasundhara, additional, Mandal, Payal, additional, Bhave, Saurabh J, additional, Garg, Jeevan Kumar, additional, Nag, Arijit, additional, Vinarkar, Sushant, additional, Parihar, Mayur, additional, Mishra, Deepak K, additional, Nair, Reena, additional, and Chandy, Mammen, additional

Published
2021
Full Text
View/download PDF

41. Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Early Safety Data from an Ongoing Single Arm Phase-II Investigator-Initiated Clinical Trial (PRIME Study)

Author

Radhakrishnan, Vivek S, primary, Tamboli, Naveed, additional, Das, Shreya, additional, Garg, Jeevan Kumar, additional, Nag, Arijit, additional, Bhave, Saurabh J, additional, Parihar, Mayur, additional, Vinarkar, Sushant, additional, Mukhopadhyay, Sumit, additional, Chakraborty, Subhosmito, additional, Mishra, Deepak K, additional, Nair, Reena, additional, and Chandy, Mammen, additional

Published
2021
Full Text
View/download PDF

43. Phenotypic Similarities Within The Morphologic Spectrum Of DICER1-Associated Sarcomas and Pleuropulmonary Blastoma -- Histopathologic Features Suggesting Genetic Testing and Counselling

Author

Roy, Paromita, primary, Das, Anirban, additional, Singh, Angad, additional, Panda, Joyshree, additional, Bhattacharya, Arpita, additional, Gehani, Anisha, additional, Parihar, Mayur, additional, Sukumaran, Reghu, additional, Achari, Rimpa, additional, Alaggio, Rita, additional, Field, Amanda, additional, Hill, Ashley, additional, Dehner, Louis, additional, and Schultz, Kris Ann, additional

Published
2021
Full Text
View/download PDF

44. Quality indicators for glioblastoma treatment: An audit from a tertiary care cancer center in India.

Author

Goyal, Love, primary, Chakraborty, Santam, additional, Saha, Saheli, additional, Roy, Paromita, additional, Zameer, Lateef, additional, Mishra, Deepak, additional, Parihar, Mayur, additional, Chandra, Aditi, additional, Arunsingh, Moses, additional, Chatterjee, Sanjoy, additional, Mallick, Indranil, additional, Bhattacharyya, Tapesh, additional, Biswas, Bivas, additional, and Basu Achari, Rimpa, additional

Published
2021
Full Text
View/download PDF

47. Inotuzumab Ozogamicin Monotherapy as an Outpatient Salvage Treatment in Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia: Compassionate Access

Author

Radhakrishnan, Vivek S., additional, Modak, Ketan, additional, Bhave, Saurabh J., additional, Kumar, Jeevan, additional, Roychowdhury, Mita, additional, Ghosh, Manik, additional, Parihar, Mayur, additional, Arora, Neeraj, additional, Mishra, Deepak K., additional, Nair, Reena, additional, and Chandy, Mammen, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results